Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,127 | 13,981 | 12,062 | 12,317 | 12,856 |
| Marketable Securities | 8,005 | 16,024 | 27,504 | 41,374 | 50,096 |
| TOTAL | $21,803 | $31,072 | $40,952 | $54,964 | $64,442 |
| Non-Current Assets | |||||
| PPE Net | 111 | 135 | 163 | 190 | 218 |
| Other Non-Current Assets | 44 | 115 | 219 | 1,538 | 1,777 |
| TOTAL | $155 | $250 | $382 | $1,728 | $1,995 |
| Total Assets | $21,958 | $31,322 | $41,334 | $56,692 | $66,437 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16,911 | 18,746 | 18,678 | 25,274 | 25,179 |
| Accounts payable and accrued liabilities | 1,817 | 1,286 | 2,412 | 2,441 | 2,363 |
| Accrued Expenses | 9,847 | 8,546 | 8,985 | 10,376 | 8,506 |
| TOTAL | $28,575 | $28,651 | $30,254 | $38,373 | $36,429 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $28,575 | $28,651 | $30,254 | $38,373 | $36,429 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,744 | 39,417 | 39,272 | 39,272 | 38,625 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -295,456 | -284,903 | -275,073 | -265,932 | -252,167 |
| Other shareholders' equity | 9 | 5,447 | 5,446 | 5,461 | 5,387 |
| TOTAL | $-6,617 | $2,671 | $11,080 | $18,319 | $30,008 |
| Total Liabilities And Equity | $21,958 | $31,322 | $41,334 | $56,692 | $66,437 |